Thought for food: Clinical evidence for the dietary prevention strategy in cardiovascular disease

International Journal of Evidence-Based Healthcare

Volumn 11, Issue 4, 2013, Pages 330-336

  Lewis, Barry ^a   Sullivan, David R ^b   Watts, Gerald F ^c  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cardiovascular disease; Dietary recommendation; Low density lipoprotein cholesterol; Mediterranean diet; Prevention

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANCESTRY GROUP; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; DIET; DIETARY RECOMMENDATION; EDITORIAL; ETHNOLOGY; FAT INTAKE; HUMAN; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; MEDITERRANEAN DIET; METABOLISM; PATHOPHYSIOLOGY; PREVENTION;

CARDIOVASCULAR DISEASE; DIETARY RECOMMENDATION; LOW-DENSITY LIPOPROTEIN CHOLESTEROL; MEDITERRANEAN DIET; PREVENTION;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, LDL; CONTINENTAL POPULATION GROUPS; DIET; DIET, MEDITERRANEAN; DIETARY FATS; HUMANS;

EID: 84888863777     PISSN: 17441595     EISSN: 17441609     Source Type: Journal    
DOI: 10.1111/1744-1609.12047     Document Type: Editorial

References (75)

1. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global burden of cardiovascular diseases: part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001; 104: 2855-2864.
2. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-372.
3. Baigent C, Keech A, Kearney PM etal. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267-1278.
4. Rose G, Colwell L. Randomised controlled trial of anti-smoking advice: final (20 year) results. J Epidemiol Community Health 1992; 46: 75-77.
5. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990; 80: 954-958.
6. Hooper L, Summerbell CD, Thompson RL etal. Reduced or modified dietary fat for preventing cardiovascular disease: systematic review. Cochrane Database Syst Rev 2011; (7): CD002137.
7. Kritchevsky D. History of recommendations to the public about dietary fat. J Nutr 1998; 128: 449S-452.
8. Keys A. Seven Countries: A Multivariate Analysis of Death and Coronary Disease. Cambridge, MA: Harvard University Press, 1980; ISBN 0-674-80237-3.
9. McGill HC, Strong JP. The geographic pathology of atherosclerosis. Ann N Y Acad Sci 1968; 149: 923-927.
10. Armstrong ML, Warner ED, Connor WE. Regression of coronary atheromatosis in rhesus monkeys. Circ Res 1970; 27: 59-67.
11. Wissler RW, Vesselinovitch D. Studies of regression of advanced atherosclerosis in experimental animals and man. Ann N Y Acad Sci 1976; 275: 363-378.
12. Hu FB, Manson, J, Willett WC. Types of dietary fat and risk of coronary heart disease: a critical review. J Am Coll Nutr 2001; 20: 5-19.
13. Skeaff CM, Miller J. Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Ann Nutr Metab 2009; 55: 173-201.
14. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010; 91: 535-546.
15. Stamler J. Diet-heart: a problematic revisit. Am J Clin Nutr 2010; 91: 497-499.
16. Keys A. Dietary survey methods. In: Levy RI, Rifkind B, Dennis BH, Ernst ND, eds. Nutrition, Lipids and Coronary Heart Disease. New York: Raven Press, 1979; 1-23.
17. Keys A. Coronary heart disease in seven countries. Circulation American Heart Association Monograph no 29 1970; 42 (Suppl. 1): I-1-I-211.
18. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008; 337: a1344.
19. Trichopoulou A, Bamia C, Trichopoulos D. Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ 2009; 338: b2337.
20. Lewis B, Hammett F, Katan M etal. Towards an improved lipid-lowering diet: additive effects of changes in nutrient intake. Lancet 1981; 2: 1310-1313.
21. Stamler JWD, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823-2828.
22. Cholesterol Treatment Triallists C. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170?000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681.
23. Mancini M, Stamler J. Diet for preventing cardiovascular diseases: light from Ancel Keys, distinguished centenarian scientist. Nutr Metab Cardiovasc Dis 2004; 14: 52-57.
24. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112-117.
25. Marmot MG, Syme SL, Kagan A, Kato H, Cohen JB, Belsky J. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: prevalence of coronary and hypertensive heart disease and associated risk factors. Am J Epidemiol 1975; 102: 514-525.
26. Food and Agricultural Organization: FAOSTAT. 2012. Accessed 2013. Available from: http://faostat.fao.org/
27. Wen C-P, Gershoff SN. Changes in serum cholesterol and coronary heart disease mortality associated with changes in the postwar Japanese diet. Am J Clin Nutr 1973; 26: 616-619.
28. Friedlander Y, Kark JD, Stein Y. Biological and environmental sources of variation in plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic. Hum Hered 1986; 36: 143-153.
29. Middleberg RP, Martin M, Whitfield JB. Longitudinal genetic analysis of plasma lipids. Twin Res Hum Genet 2006; 9: 550-557.
30. Aulchenko YS, Ripatti, S, Lindqvist I, Boomsma D and the ENGAGE Consortium. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009; 41: 47-55.
31. Heller DA, de Faire U, Pedersen NL, Dahlen G, McCleary G. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med 1993; 328: 1150-1156.
32. Masson LF, McNeill J, Avenell A Genetic variation in the lipid response to dietary intervention: a systematic review. Am J Clin Nutrit 2003; 77: 1098-1111.
33. Miettinen M, Turpeinen O, Karvonen MJ, Elosuo R, Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet 1972; 2: 835-838.
34. Dayton S, Pearce ML. Diet high in unsaturated fat. A controlled clinical trial. Minn Med 1969; 52: 1237-1242.
35. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982; 248: 1465-1477.
36. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group. JAMA 1990; 263: 1795-1801.
37. Hjermann I, Velve Byre K, Holme I, Leren P. Effect of diet and smoking intervention on the incidence of coronary heart disease. Report from the Oslo Study Group of a randomised trial in healthy men. Lancet 1981; 2: 1303-1310.
38. Garfinkel L. Trends in cigarette smoking in the United States. Prev Med 1997; 26: 447-450.
39. Nammi S, Koka S, Chinnala K, Boini K. Obesity: an overview on its current perspectives and treatment options. Nutr J 2004; 3: 3.
40. Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol Biol 2010; 610: 403-417.
41. Krauss RM. Atherogenic lipoprotein phenotype and diet-gene interactions. J Nutr 2001; 131: 340S-343.
42. Blankenhorn DH, Johnson R, Mack WJ, el Zein HA, Vailas LI. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990; 263: 1646-1652.
43. Ornish D, Brown SE, Scherwitz LW etal. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-133.
44. Watts GF, Lewis B, Brunt JN etal. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563-569.
45. Watts GF, Jackson P, Burke V, Lewis B. Dietary fatty acids and progression of coronary artery disease in men. Am J Clin Nutr 1996; 64: 202-209.
46. Shai I, Spence JD, Schwarzfuchs D etal. Dietary intervention to reverse carotid atherosclerosis. Circulation 2010; 121: 1200-1208.
47. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr 1965; 17: 281-295.
48. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
49. Halvorsen BL, Blomhoff R. Determination of lipid oxidation products in vegetable oils and marine omega-3 supplements. Food Nutr Res 2011; 55: doi: 10.3402/fnr.v55i0.5792.
50. Mata P, Alonso R, Lopez-Farre A etal. Effect of dietary fat saturation on LDL oxidation and monocyte adhesion to human endothelial cells in vitro. Arterioscler Thromb Vasc Biol 1996; 16: 1347-1355.
51. Lichtenstein AH, Deckelbaum RJ, Committee ftAHAN. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation 2001; 103: 1177-1179.
52. Clifton PM, Mano M, Duchateau GS, van der Knaap HC, Trautwein EA. Dose-response effects of different plant sterol sources in fat spreads on serum lipids and C-reactive protein and on the kinetic behavior of serum plant sterols. Eur J Clin Nutr 2008; 62: 968-977.
53. Tribble DL, Committee FtN. Antioxidant consumption and risk of coronary heart disease: emphasis on vitamin C, vitamin E, and β-carotene: a statement for healthcare professionals from the American Heart Association. Circulation 1999; 99: 591-595.
54. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354: 1601-1613.
55. Lahoz C, Alonso R, Ordovas JM, Lopez-Farre A, de Oya M, Mata P. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. Eur J Clin Invest 1997; 27: 780-787.
56. Uauy R. Fat and fatty acid intake and metabolic effects in the human body on insulin sensitivity, inflammatory markers and endothelial function. FAO Food and nutrition report of an expert consultation fat and fatty acids in human nutrition 2008; 91, Chapter 10:113-128.
57. Jakobsen MU, Dethlefsen C, Joensen AM etal. Intake of carbohydrates compared with intake of saturated fatty acids and risk of myocardial infarction: importance of the glycemic index. Am J Clin Nutr 2010; 91: 1764-1768.
58. de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99: 779-785.
59. de Lorgeril M, Renaud S, Mamelle N etal. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343: 1454-1459.
60. Estruch R, Ros E, Salas-Salvado J etal. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279-1290.
61. Truswell S. Cholesterol and Beyond: The Research on Diet and Coronary Heart Disease 1900-2000 Dordrecht. New York: Springer, 2010; ISBN 978-90-481-8874-1:121-4.
62. Hu FB, Stampfer MJ, Manson JE etal. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337: 1491-1499.
63. Ramsden CE, Zamora D, Leelarthaepin B etal. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013; 346: e8707.
64. Page IH, Allen EV, Chamberlain FL, Keys A, Stamler J, Stare FJ. Dietary fat and its relation to heart attacks and strokes. Circulation 1961; 23: 133-136.
65. Ahrens EH Jr, Hirsch J, Peterson ML, Stoffel W, Farquhar JW. Symposium on significance of lowered cholesterol levels. JAMA 1959; 170: 2198-2199.
66. Lewis B, Tikkanen MJ. Low blood total cholesterol and mortality: causality, consequence and confounders. Am J Cardiol 1994; 73: 80-85.
67. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
68. Walshe V, Nash A, Barry M. Cost effectiveness of statin therapy for the primary prevention of coronary heart disease. Ir Med J 2006; 99: 144-145.
69. Force SST. Symposium: report of the National Lipid Association statin safety task force. Am J Cardiol 2006; 97: 1C-97C.
70. Aubert RE, Yao J, Xia F, Garavaglia SB. Is there a relationship between early statin compliance and a reduction in healthcare utilisation? Am J Manag Care 2010; 16: 459-466.
71. Anon. A fat chance. The Economist 2012;November 17.
72. Anon. New York City soda ban blocked by judge. New York Times 2013;March 11th 2013.
73. Moss M. The extraordinary addictive science of addictive junk food. New York Times magazine 2013;February 20th 2013.
74. Lichtenstein AH, Appel LJ, Brands M etal. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006; 114: 82-96.
75. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3-10.